The New Theatre Building (240 East 10th Street)
1. BUILDING OVERVIEW (ANALYST FRAMING)
Building Type: Postwar Resale Condo (Built 2001)
Scale: 16 Floors, 37 Units
Classification: Yield-Oriented (Currently in Equity Correction)
Justification: Post-sponsor resale data identifies The New Theatre Building as a severe "Equity Trap" for buyers from the 2015–2016 cycle. While the NYXRCSA Index rallied to all-time highs in 2025 (~330), resale pricing in this building has regressed. Multiple units sold in 2024–2025 for less than their purchase prices 6–9 years prior. The asset functions primarily as a rental vehicle (Yield-Oriented), generating consistent income ($70–$85 PPSF rents), but it has failed to capture capital appreciation during the most recent market boom.
2. UNIT MIX & COMPOSITION
Data Basis: Transaction-weighted inventory (N=63 sales).
Composition:
2-Beds (~1,100–1,500 SF): The dominant inventory (~80% of activity).
Smaller 2-Beds (B/D Lines): ~1,100–1,145 SF.
Larger 2-Beds (A/C Lines): ~1,340–1,496 SF.
3-Beds / PH: Rare inventory (~2,500+ SF). High volatility.
Impact: The building is a "2-Bedroom Factory." The high interchangeability of the 1,100 SF units creates a ceiling on prices. If one seller asks for a premium, buyers simply shift to the identical unit on a different floor, suppressing breakout appreciation.
3. LINE (STACK) PERFORMANCE — RESALE ONLY
Sponsor normalization applied: Excluded 2003–2004 initial closings from liquidity metrics.
A. Liquidity (Speed)
Rank 1 (Fastest): B-Line (Smaller 2-Beds). e.g., Unit 4B (2025) cleared in 15 days.
Rank 2 (Slowest): A/D Lines (Recent). e.g., Unit 5D (110 days), Unit 4A (off-market/lag).
Recent Shift (2024–2025): Volatile.
Unit 4B (2025): 15 Days (Hyper-liquid).
Unit 8A (2026): 95 Days.
Unit 5D (2025): 110 Days.
Conclusion: Liquidity is inconsistent. Pricing accurately keeps it liquid (4B), but aspirational pricing leads to 3+ month delays.
B. Appreciation (Durability)
A-Line (Large 2-Bed): Depreciating.
Unit 4A Sold 2016: $1.96M.
Unit 4A Sold 2025: $1.66M.
Result: -15% Nominal Loss over 9 years.
C-Line (Large 2/3 Bed): Depreciating.
Unit 10C Sold 2016: $2.65M.
Unit 10C Sold 2023: $2.25M.
Result: -15% Nominal Loss over 7 years.
D-Line: Stagnant.
Unit 5D Sold 2019: $1.495M.
Unit 5D Sold 2025: $1.490M.
Result: Flat (Real loss after inflation).
4. BUILDING-WIDE PPSF TREND (NORMALIZED)
Growth Phase (2004–2016): Strong compounding. PPSF rose from ~$800–$1,000 to peak levels of ~$1,800–$1,980.
Correction Phase (2017–2025): The Decoupling.
2016 Peak: Unit 12A @ $1,980 PPSF. Unit 10C @ $1,771 PPSF.
2025 Reality:
Unit 4A: $1,238 PPSF.
Unit 5D: $1,354 PPSF.
Unit 4B: $1,637 PPSF.
Trend: Cyclical Drawdown. The building is trading at 2011–2012 pricing levels ($1,200–$1,500 PPSF). This contrasts sharply with the NYXRCSA Index, which rose from ~180 (2012) to ~330 (2025).
5. RENT CAPTURE ANALYSIS
A. Rent Capture by Line
2-Beds (C Line):
Unit 8C (2023): $8,995 ($72 PPSF). DOM: 16 Days.
Unit 6C (2020): $9,000.
Stability: Rents are flat ($9k in 2020 vs $9k in 2023).
2-Beds (A Line):
Unit 12A (2023): $9,000 ($81 PPSF). DOM: 66 Days.
Yield Calculation (Unit 8C Proxy):
2023 Sale Price: $2.97M.
Annual Rent: ~$108k.
Gross Yield: ~3.6%.
Analyst Note: This yield is low for a "Yield-Oriented" building, suggesting prices on upper floors (Unit 8C) are still disconnected from rental reality, or rental demand is softer than sales demand.
B. Conclusion Rent capture is moderate ($70–$85 PPSF). It lacks the "turbocharged" returns seen in other East Village condos (often $100+ PPSF). DOM for rentals is often high (60+ days), indicating tenant resistance to current asking rents.
6. B³ SCORING SYSTEM (0–100)
(Scores 0–100 based on Normalized Data)
A. Liquidity Score: 50/100
Penalty: Inconsistent DOM. While Unit 4B sold in 15 days, Unit 5D took 110 days and Unit 8C took 198 days (in 2023).
Penalty: Significant price cuts required to move inventory (e.g., Unit 10C sold -18% below 2016 price).
B. Rent Capture Score: 70/100
Strength: Established rental history.
Penalty: Low Yields on premium units (~3.5%).
Penalty: High Rental DOM (Median ~45–60 days).
C. Appreciation Score: 20/100
Penalty: Multiple confirmed realized losses between 2016–2025.
Penalty: Massive underperformance against NYXRCSA benchmark (Index +80% vs Building -15%).
Support: Long-term holders (2004 buyers) are still up, preventing a score of 0.
7. COMPOSITE SCORE & CLASSIFICATION
Composite Score: 45.5 (Liquidity 50 × 0.35) + (Rent 70 × 0.30) + (Appreciation 20 × 0.35)
Classification: Yield-Oriented
Definition: A "Depreciating Asset" with cash flow. The building generates steady rent, but equity value has eroded significantly for anyone who bought in the last decade.
8. TRANSACTION EXAMPLES
Resale Depreciation (The "Leakage"):
Unit 4A (2-Bed):
Bought May 2016: $1,960,000
Sold Jun 2025: $1,660,000
Result: -15.3% Loss over 9 years.
Driver: Market Regime Timing (Bought at 2016 peak) & Liquidity Shift.
Unit 10C (3-Bed):
Bought Jun 2016: $2,650,000
Sold Nov 2023: $2,250,000
Result: -15.1% Loss over 7 years.
Driver: Market Regime Timing.
Unit 5D (2-Bed):
Bought May 2019: $1,495,000
Sold Apr 2025: $1,490,000
Result: Flat (-0.3%) nominal change over 6 years.
Real Impact: Significant loss after inflation and transaction costs.
Driver: Line-level premium persistence (weak).
Resale Appreciation (Long-Term Holds):
Unit 11B (2-Bed):
Bought Jul 2010: $1,299,000
Sold Aug 2024: $1,960,000
Result: +51% over 14 years.
Driver: Market Regime Timing (Bought post-GFC).
Unit 8C (2-Bed):
Bought Jun 2013: $2,269,000
Sold Apr 2023: $2,968,900
Result: +30% over 10 years (~2.7% CAGR).
Driver: Market Regime Timing (Caught the 2013-2023 rise).
Unit 4B (2-Bed):
Bought Mar 2015: $1,625,000
Sold Jul 2025: $1,875,000
Result: +15% over 10 years (~1.4% CAGR).
Context: NYXRCSA Index rose ~80% in this period.
Driver: Liquidity Shift (Underperformance).
9. RISKS & RED FLAGS
Red Flag: The 2016 "Death Zone." Any unit purchased between 2015 and 2017 is currently trading at a loss or break-even. The building has not recovered its pre-pandemic peak valuations.
Risk: PPSF Dispersion. In 2025, Unit 4A sold for $1,238 PPSF while Unit 4B sold for $1,637 PPSF just one month later. This massive discrepancy ($400/ft) on the same floor indicates extreme valuation uncertainty or specific unit condition issues (e.g., renovations vs. original condition).
Opportunity Cost: While the NYXRCSA Index hit 330 in late 2025, this building is trading at levels comparable to 2011–2012. It has completely missed the post-COVID boom.
10. EXECUTIVE SUMMARY
The New Theatre Building (240 East 10th Street) is a Yield-Oriented asset currently functioning as an "Equity Trap" for medium-term holders. Post-sponsor analysis reveals a sharp decoupling from the broader market: while the NYXRCSA Index surged to record highs in 2025, resale prices in this building have reverted to levels seen a decade ago. Investors who bought in 2016 have realized ~15% nominal losses in 2023–2025 sales. While the building offers stable rental inventory (2-beds rent for ~$9,000), yields are modest (~3.6% on premium units), and liquidity is volatile. Buyers should demand aggressive discounts (targeting ~$1,200–$1,300 PPSF) to insulate against the building's proven lack of appreciation.
DISCLOSURES & NORMALIZATION
Sponsor Normalization:
Sales from 2003–2004 (Initial offering) were treated as Sponsor baselines.
These were excluded from Resale Liquidity metrics.
Data Note:
Unit 4A (2025): The low PPSF ($1,238) relative to Unit 4B ($1,637) suggests Unit 4A may have been unrenovated or distressed, dragging down building averages.
Unit 15/15AB: High-floor combination units were treated as outliers for PPSF benchmarking due to lack of comparable inventory.